SCHEMBL5556207

SCHEMBL5556207

CN(C)C(=O)Nc1nc2c(s1)-c1c(cnn1-c1ccccc1)CC2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.40
NPC1 O15118 3/20 0.40
RAB9A P51151 3/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
TP53 P04637 1/20 0.40
POLB P06746 1/20 0.40
DRD4 P21917 1/20 0.40
KDM4E B2RXH2 2/20 0.37
L3MBTL1 Q9Y468 1/20 0.36
CA2 P00918 2/20 0.36
CA4 P22748 2/20 0.36
CA9 Q16790 2/20 0.36
PIK3CG P48736 3/20 0.36
TSHR P16473 1/20 0.35
TRPV4 Q9HBA0 1/20 0.35
GAA P10253 1/20 0.35
PIK3CD O00329 2/20 0.35
PIK3CA P42336 2/20 0.35
PIK3CB P42338 2/20 0.35
PI4KA P42356 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4078512 0.91 KDM4E (0.37) ALDH1A1NPC1RAB9ASMN1; SMN2TP53
SCHEMBL2143831 0.89 PIK3CG (0.46) ALDH1A1NPC1RAB9ASMN1; SMN2TP53
SCHEMBL11942158 0.87 ALOX5 (0.41) ALDH1A1NPC1RAB9ASMN1; SMN2TP53
SCHEMBL5552478 0.87 ALDH1A1 (0.41) ALDH1A1NPC1RAB9ASMN1; SMN2TP53
SCHEMBL4510261 0.86 NPC1 (0.42) ALDH1A1NPC1RAB9ASMN1; SMN2TP53
SCHEMBL14817951 0.85 ALDH1A1 (0.40) ALDH1A1NPC1RAB9ASMN1; SMN2TP53
SCHEMBL5552332 0.85 PI4KA (0.42) ALDH1A1NPC1RAB9ASMN1; SMN2TP53
SCHEMBL2143847 0.84 ALDH1A1 (0.41) ALDH1A1NPC1RAB9ASMN1; SMN2TP53
SCHEMBL5556915 0.84 ALDH1A1 (0.41) ALDH1A1NPC1RAB9ASMN1; SMN2TP53
SCHEMBL5556947 0.84 NPC1 (0.47) ALDH1A1NPC1RAB9ASMN1; SMN2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070259855-A1 THIAZOLYL-DIHYDRO-INDAZOLE BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-11-08 US claimed
US-20070259855-A1 THIAZOLYL-DIHYDRO-INDAZOLE BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-11-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070259855-A1 THIAZOLYL-DIHYDRO-INDAZOLE ROR1, RORB, RORA ALDH1A1 60/4885NPC1 2469/4885RAB9A 471/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.